Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ambit Biosciences Inc.

Division of Daiichi Sankyo Co. Ltd.
www.ambitbio.com

Latest From Ambit Biosciences Inc.

Japan 2010s In Review: Specialize, Focus, Innovate

Corporate consolidation and specialization were major threads running through the 2010s in Japan. Reimbursement pricing issues continued to dominate the policy sphere while new forms of therapy benefited from positive regulatory reforms.

Japan Business Strategies

Multiple Firsts As Pexidartinib Approved In US - With Warning

Further progress for Daiichi Sankyo's strategic push into oncology as US issues first approval globally for first-in-class rare disease drug Turalio - but with liver toxicity safeguards.

United States Approvals

AML Contender Quizartinib Gains First Approval, In Japan

Japan grants first approval worldwide for Daiichi Sankyo's oral FLT3 inhibitor, marking progress for Japanese firm's global oncology ambitions.

Japan Approvals

Daiichi Denies OTC Business Sale But Would It Make Sense?

Daiichi Sankyo denies report it is in negotiations to sell its OTC business, but might such a move actually align well with mid-term strategy?

 

Japan OTC Drugs
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Inflammation
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Daiichi Sankyo Co. Ltd.
  • Senior Management
  • Michael A Martino, Pres. & CEO
    Alan Fuhrman, CFO
  • Contact Info
  • Ambit Biosciences Inc.
    Phone: (858) 334-2100
    4215 Sorrento Valley Blvd.
    San Diego, CA 92121
    USA
UsernamePublicRestriction

Register